New Reporting Requirement for Psychedelic Drugs in VA Healthcare

The Frame

What this does

This legislation establishes a mandatory 180-day timeline for the VA to justify its coverage decisions regarding emerging psychedelic treatments, directly impacting the availability of these therapies for veterans enrolled in the VA healthcare system.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Veterans enrolled in VA healthcare

The bill dictates the timeline and transparency of decisions regarding the availability of new psychedelic treatments within their healthcare system.

Secretary of Veterans Affairs

The Secretary is mandated to perform new reporting duties and provide justifications for formulary decisions.

What changed

Last recorded activity September 6, 2024.

What's next

Introduced.

Summary

This bill requires the Secretary of Veterans Affairs to submit a formal report to Congress explaining whether or not the Department will include newly FDA-approved or licensed psychedelic drugs in its official list of covered medications.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

This legislation establishes a mandatory 180-day timeline for the VA to justify its coverage decisions regarding emerging psychedelic treatments, directly impacting the availability of these therapies for veterans enrolled in the VA healthcare system.

Frequently Asked Questions

Does this bill force the VA to cover psychedelic drugs?

No. The bill only requires the Secretary of Veterans Affairs to report their decision and provide a justification for whether or not they will include a newly approved psychedelic drug in the VA .

How quickly must the VA report on a new drug?

The Secretary must submit the report to the Committees on Veterans' Affairs of the Senate and House of Representatives not later than 180 days after the drug is approved or licensed.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Formalizing Psychedelic Review

The bill signals a move toward integrating specific, emerging drug classes into the VA's formal administrative review and reporting framework.

Veterans Affairs

Connected Entities

organizationSecretary of Veterans Affairs“The executive branch official responsible for overseeing VA operations.”Map →

bill_numbertitle 38, United States Code“The specific section of the U.S. Code being amended.”Map →

othercertain psychedelic drugs“Specifically, the bill references research into drugs like psilocybin and MDMA.”Map →

organizationDepartment of Veterans Affairs“The federal agency responsible for providing benefits and services to veterans.”Map →

otherUnited States Code“The official codified collection of federal laws.”Map →

Analysis Score

0–100

Significance65
How much this matters to a regular citizen
Controversy40
Intensity of disagreement among stakeholders
Entertainment10
Compellingness for a non-policy-wonk reader
Buzz35
Current news / social attention level